全文获取类型
收费全文 | 27827篇 |
免费 | 2399篇 |
国内免费 | 1670篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 396篇 |
妇产科学 | 101篇 |
基础医学 | 3588篇 |
口腔科学 | 82篇 |
临床医学 | 2474篇 |
内科学 | 12476篇 |
皮肤病学 | 123篇 |
神经病学 | 91篇 |
特种医学 | 498篇 |
外国民族医学 | 4篇 |
外科学 | 951篇 |
综合类 | 5318篇 |
现状与发展 | 11篇 |
预防医学 | 2054篇 |
眼科学 | 12篇 |
药学 | 2045篇 |
9篇 | |
中国医学 | 1181篇 |
肿瘤学 | 474篇 |
出版年
2024年 | 31篇 |
2023年 | 344篇 |
2022年 | 599篇 |
2021年 | 755篇 |
2020年 | 806篇 |
2019年 | 946篇 |
2018年 | 847篇 |
2017年 | 930篇 |
2016年 | 1115篇 |
2015年 | 1135篇 |
2014年 | 1760篇 |
2013年 | 1848篇 |
2012年 | 1659篇 |
2011年 | 1970篇 |
2010年 | 1459篇 |
2009年 | 1328篇 |
2008年 | 1368篇 |
2007年 | 1487篇 |
2006年 | 1452篇 |
2005年 | 1178篇 |
2004年 | 1025篇 |
2003年 | 915篇 |
2002年 | 844篇 |
2001年 | 848篇 |
2000年 | 702篇 |
1999年 | 549篇 |
1998年 | 490篇 |
1997年 | 463篇 |
1996年 | 424篇 |
1995年 | 414篇 |
1994年 | 352篇 |
1993年 | 300篇 |
1992年 | 265篇 |
1991年 | 191篇 |
1990年 | 157篇 |
1989年 | 126篇 |
1988年 | 138篇 |
1987年 | 113篇 |
1986年 | 87篇 |
1985年 | 94篇 |
1984年 | 79篇 |
1983年 | 50篇 |
1982年 | 54篇 |
1981年 | 46篇 |
1980年 | 47篇 |
1979年 | 27篇 |
1978年 | 34篇 |
1977年 | 20篇 |
1974年 | 5篇 |
1973年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
R. C. Dickson M. J. Gaffey M. B. Ishitani T. P. Roarty C. J. Driscoll S. H. Caldwell 《Journal of viral hepatitis》1997,4(2):121-128
SUMMARY. Clinical and laboratory findings of autoimmunity are common in chronic hepatitis C. Autoimmune hepatitis (AIH), a disease of unknown cause, has been defined by use of the International Autoimmune Hepatitis Group Score (AIH score), which quantifies clinical and laboratory parameters. To further validate the specificity of the International AIH score and investigate the similarities between hepatitis C and AIH, we measured the International Autoimmune Hepatitis Group Score in patients with well-defined chronic hepatitis C. Thirty consecutive non-cirrhotic patients with chronic hepatitis C were evaluated. Scoring was performed using both components of the AIH score: a set of minimum required parameters including laboratory and historical data and a second set of additional parameters dominated by histological criteria. Autoantibodies were positive in 21 of 30 hepatitis C patients and associated (patient or first-degree relative) autoimmune diseases were present in eight of 30 patients. Histologically, chronic active hepatitis with periportal piecemeal necrosis was seen in 24 of 30 patients and lymphoid follicles in 16 of 30 patients. No patient scored as probable or definite AIH using the minimum required parameters of the AIH score. When histological parameters were included, four of 30 patients scored as probable AIH but none as definite AIH. Therefore, AIH was excluded by the minimal and additional criteria of the AIH score in 86% of patients with hepatitis C despite a high prevalence of autoantibodies in these patients. We conclude that the criteria set forth by the International AIH scoring system defines a distinct disease although it shares some features with chronic hepatitis C. Modification of the AIH scoring system to include other commonly accepted risk factors for hepatitis C and additional histological parameters would further improve its specificity. 相似文献
992.
Terukatsu Arima M.D. Chisato Mori Akihisa Takamizawa Hiroyuki Shimomura Takao Tsuji 《Journal of gastroenterology》1990,25(2):218-222
A random primed lambda gtll-cDNA library was constructed from donors plasma presumably infected by blood-borne non-A, non-B
hepatitis (hepatitis C:HC) agent and immunoscreened with serum pooled from patients with acute or chronic HC. Twelve lambda
gtll-cDNA clones encoding antigens associated with HC infection in Japan as well as in the USA were isolated. Of these one
clone consisting of 114 nucleotides and showing a discrete band on an immunoblot analysis, was extensively studied. The clone
is not derived from the host DNA encoding one polypeptide specific and highly sensitive for serum from patients with HC and
has no homology to the nucleotide sequences of known human viruses including hepatitis A, B and D viruses, Ebstein-Barr virus,
coxsackievirus, immunodeficiency virus type 1 or Japanese encephalitis virus. These results suggest that this clone is derived
from the genome of HC agent. 相似文献
993.
Pierluigi Toniutto Carlo Fabris Edmondo Falleti Annarosa Cussigh Elisabetta Fontanini Davide Bitetto Ezio Fornasiere Rosalba Minisini Tullia De Feo Francesca Marangoni Mario Pirisi 《Liver international》2008,28(2):257-263
Background/Aims: Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, being a putative steatogenic factor, may promote liver fibrosis progression in patients with chronic hepatitis C. This study aimed to verify the role of recipient MTHFR polymorphism in favouring graft fibrosis progression in patients with recurrent HCV after orthotopic liver transplantation (OLT). Methods: We studied 63 such patients, followed for >1 year. MTHFR allelic variants were determined by a polymerase chain reaction/restriction fragment length polymorphism method. Results: Recipients carrying the TT genotype had more frequently, 1‐year post‐OLT, homocysteine serum levels >23 μmol/L (P<0.05), serum triglycerides >180 mg/dL (P<0.02) and de novo diabetes mellitus (P<0.05) but not a higher frequency of graft steatosis. Time‐to‐event analysis in reaching an Ishak staging score >2 was performed by stratifying the recipients as follows: (a) patients with donor age ≤45 years, (b) patients with donor age >45 and C/* genotype, and (c) patients with donor age >45 years and TT genotype. A significant linear trend was observed, with increasing frequencies as follows: (a) 8/37, (b) 10/19 and (c) 6/7 (P=0.0005). Conclusion: The MTHFR C677T polymorphism may play a role in influencing liver fibrosis progression in patients with recurrent hepatitis C, in conjunction with donor age, but not via steatosis promotion. 相似文献
994.
拉米夫定治疗慢性乙肝病毒感染病人的疗效分析 总被引:1,自引:0,他引:1
目的:观察拉米夫定(Lamivudine)治疗慢性乙肝病毒(HBV)感染病人的疗效及影响因素。方法:60例慢性HBV感染病人予拉米夫定(100mg qd)治疗12个月。疗效评估包括血清HBV病毒学、血清HBV免疫学、血清生化学应答率。结果:治疗12个月后,HBV DNA PCR荧光定量检测总的血清HBV DNA转阴率为57.89%,HBeAg/抗-HBe血清转换率为6.25%,ALT复常率为68.89%。其中,(1)血清ALT异常、HBeAg阳性组病人的荧光定量检测HBV DNA转阴率为55.56%,HBeAg/抗-HBe血清转换率为8.33%,ALT恢复正常率为63.89%;完全应答率为8.33%,部分应答率为75.00%,无应答率为16.67%。(2)ALT正常、HBeAg阳性组的12例病人中,仅有4例病人的血清HBV DNA转阴,无1例发生HBeAg/抗-HBe血清转换。(3)ALT异常、HBeAb阳性组的9例病人中,8例病人的HBV DNA转阴同时伴ALT复常。结论:本组病例分析结果表明,拉米夫定可以有效地抑制血清HBV的复制,改善肝功能。机体免疫状况对拉米夫定抗病毒治疗有较大影响,治疗前ALT水平是预测疗效的重要指标。对ALT异常的慢性HBV感染病人,HBeAg阴性者似乎比HBeAg阳性者有更好的治疗反应,可能更适合用拉米夫定治疗。病人对拉米夫定普遍耐受性良好。 相似文献
995.
Cheng-Peng Zhong Zhi-Feng Xi Qiang Xia 《Hepatobiliary & pancreatic diseases international : HBPD INT》2018,17(1):27-31
Background: Autoimmune liver diseases(ALDs) consist of autoimmune hepatitis(AIH), primary biliary cirrhosis(PBC), primary sclerosing cholangitis(PSC), Ig G4-associated cholangitis and overlap syndromes.Patients with these diseases may gradually progress to end-stage liver diseases and need liver transplantation. The present study aimed to explore the prognosis of patients with ALDs after liver transplantation.Methods: The clinical data of 80 patients with ALD(24 cases of AIH, 35 of PBC, 15 of PSC and 6 of AIHPBC overlap syndromes) who underwent liver transplantation in Renji Hospital, Shanghai Jiao Tong University School of Medicine from June 2004 to September 2016 were collected retrospectively. The causes of death were analyzed and the postoperative cumulative survival rate was estimated by the Kaplan–Meier method. Recurrence and other complications were also analyzed.Results: Of the 80 patients, 18 were males and 62 were females. The average age was 50.5 years and the average Model for End-stage Liver Disease(MELD) score was 14.1. After a median follow-up of 19.8 months, 8 patients died. The 1-, 3-and 5-year cumulative survival rates were all 89.0%. Three cases of recurrent ALDs were diagnosed(3.8%) but they were not totally consistent with primary diseases. Biliary tract complication occurred in 10 patients(12.5%). The new onset of tumor was observed in 1 patient(1.3%). De novo HBV/CMV/EBV infection was found in 3, 8 and 3 patients, respectively.Conclusion: Liver transplantation is an effective and safe treatment for end-stage ALD. 相似文献
996.
Wali M Lewis S Hubscher S Harrison R Ahmed M Elias E Mutimer D 《Journal of viral hepatitis》1999,6(6):445-452
Assessment of prognosis from hepatitis requires liver histology. When the fibrosis stage is known, and if the fibrosis progression rate can be established, time to development of cirrhosis can be calculated. The fibrosis progression rate can be calculated from a single biopsy when duration of infection prior to biopsy is known. Sequential biopsies can also be examined. In this work, we studied histological activity and fibrosis stage in liver biopsies of 157 hepatitis C virus (HCV)-infected patients, including 92 for whom the approximate duration of infection was known. The mean fibrosis progression rate was 0.09 units per year, and was not influenced by mode of infection or viral genotype. Forty-six patients who had very mild histological changes in the initial biopsy underwent repeat biopsy 2 years later (with no intervening anti-viral treatment). Comparison of paired biopsies confirmed a tendency to histological progression and increasing hepatic fibrosis (mean, 0.15 fibrosis units per year). A normal baseline alanine aminotransferase (ALT) value was associated with slow fibrosis progression before baseline biopsy and between biopsies. These data do not differ from published cross-sectional and longitudinal studies, and suggest that histological progression will be observed during follow-up of most patients, including those with mild histological changes at time of initial assessment. 相似文献
997.
Cloning of the non-structural gene 3 of hepatitis C virus and its inducible expression in cultured cells 总被引:6,自引:0,他引:6
METHODSThens3genewasobtainedfromplasmidpBns3bypolymerasechainreactionandinsertedintothecloningvectorpGEMT.Then,thens3wassubc... 相似文献
998.
Hatano R Ebara M Fukuda H Yoshikawa M Sugiura N Kondo F Yukawa M Saisho H 《Journal of gastroenterology and hepatology》2000,15(7):786-791
BACKGROUND AND AIMS: Relationships between chronic liver disease and trace metals have not been clearly understood. To examine connections between severity of hepatic fibrosis in chronic hepatitis C and copper, iron and zinc we measured the contents of these metals in liver tissue and serum in the patients. METHODS: Forty-one patients (26-62 years), 13 with fibrosis representing grade F1, 16 with F2, seven with F3, and five with F4, entered this study. Metals were quantified in needle liver-biopsy specimens by particle-induced X-ray emission. In serum, metals were measured by flameless atomic absorption spectrometry. RESULTS: Hepatic copper content increased with progression of hepatic fibrosis (P < 0.05). The copper content correlated positively with bilirubin (r = 0.466, P = 0.0023), and with type IV collagen (r = 0.402, P = 0.0086) and correlated negatively with albumin (r = -0.404, P = 0.080). However, hepatic iron and zinc contents did not show a significant differences between grades of fibrosis. CONCLUSIONS: Copper accumulation in fibrotic livers caused by chronic hepatitis C may contribute to hepatic injury. The real mechanism is not known at present, but excess copper may damage the liver by oxidative stress. 相似文献
999.
Reappearance of HBsAg with compartmentalized different HBV strains in allograft versus PBMC of the recipient 总被引:1,自引:0,他引:1
A woman who was positive for anti-hepatitis B surface antigen (anti-HBs) and anti-hepatitis B core antigen (anti-HBc) received
an orthotopic liver transplantation from an anti-HBc-seropositive donor in November 1985. Reappearance of hepatitis B surface
antigen (HBsAg) was noted 5 months after the transplantation, but it was not associated with significant liver inflammation.
Ten years after the transplantation, results of serum hepatitis B virus (HBV) DNA study, by nested polymerase chain reaction,
were negative. However, HBV DNA was detected in the transplanted liver tissues and peripheral blood mononuclear cells. Different
strains were identified in these two organs. An adw strain was found in the transplanted liver, whereas an adr strain with
long segment deletions in the core gene was found in the peripheral blood mononuclear cells. Covalently closed circular HBV
DNA was not detected in any of the tissues examined. Occult HBV infection in the donor as well as the recipient is common
in HBV endemic areas. The recipient in this case had reappearance of hepatitis B surface antigen (HBsAg) in the serum after
transplantation. Nevertheless, 10 years later, two different strains of HBV were identified in different organs, without cross
infection. The present case demonstrates that HBsAg reappearance was not associated with reactivation of the virus and liver
inflammation. This type of HBsAg reappearance did not appear to produce a significant hazard to the transplanted liver.
Received: December 16, 1999 / Accepted: May 26, 2000 相似文献
1000.
Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease
Duarte MP Farias ML Coelho HS Mendonça LM Stabnov LM do Carmo d Oliveira M Lamy RA Oliveira DS 《Journal of gastroenterology and hepatology》2001,16(9):1022-1027
BACKGROUND: The main process involved in hepatic osteodystrophy seems to be osteoporosis, but decreased 25-hydroxylation of vitamin D might lead to osteomalacia and secondary hyperparathyroidism. METHODS AND RESULTS: We studied bone mineral density (BMD) by using DEXA-Expert Lunar, biochemical markers of bone turnover and calcium-parathyroid hormone (PTH)-vitamin D axis in 100 patients with chronic viral hepatitis secondary to hepatitis C virus: 49 non-cirrhotic (NCir) and 51 with cirrhosis (Cir) confirmed by liver biopsy and/or clinical and biochemical features. When compared to the age-matched population, 25% of the patients had low BMD at the lumbar spine (LS), 26.2% at Ward's triangle, 15.5% at the femoral neck (FN), and 20.2% at the trochanter. No difference was found either between Cir and NCir groups or between sexes. Urinary N-telopeptide was increased in 31.86% of the patients, and negatively correlated with BMD at the LS and trochanter (P < 0.02). Serum bone-specific alkaline phosphatase was elevated in 21% of the patients and negatively correlated with BMD at the trochanter and Ward's triangle (P < 0.02). Fasting 25-hydroxyvitamin D was low in only three Cir patients, with no difference between the Cir and NCir groups, but it was higher in men (51.8 +/- 16.0 ng/mL) compared to women (40.4 +/- 14.4 ng/mL; P = 0.001). Fasting serum calcium was lower in Cir than NCir patients, P = 0.019. Fasting intact PTH was elevated in 42% of the patients, but the mean serum levels were similar in Cir and NCir groups. CONCLUSION: We found no evidence of vitamin D deficiency, but cannot exclude the participation of PTH in the high bone turnover and bone loss in the population with chronic viral hepatitis. 相似文献